Scienture Holdings, Inc. (SCNX) reported preliminary, unaudited revenue of approximately $1.22 million for the third quarter ended September 30, 2026, up 256% from approximately $344,000 in the second quarter.
The company attributed the sequential increase to the August 2026 commercial launch of REZENOPY and initial wholesale shipments, alongside continued sales growth and broader market adoption of Arbli.
- Preliminary Q3 2026 revenue was approximately $1.22 million.
- Revenue increased 256% sequentially from approximately $344,000 in Q2 2026.
- Arbli wholesale unit sales increased 74% sequentially.
- REZENOPY launched commercially in August 2026.
- Scienture said full Q3 2026 financial results will be included in its forthcoming Form 10-Q filing.
$SCNX Hedge Fund Activity
We have seen 7 institutional investors add shares of $SCNX stock to their portfolio, and 6 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 235,117 shares (+inf%) to their portfolio in Q2 2026, for an estimated $82,290
- HRT FINANCIAL LP added 132,669 shares (+inf%) to their portfolio in Q2 2026, for an estimated $46,434
- GEODE CAPITAL MANAGEMENT, LLC removed 97,219 shares (-22.5%) from their portfolio in Q2 2026, for an estimated $34,026
- NORTHERN TRUST CORP added 73,712 shares (+530.5%) to their portfolio in Q2 2026, for an estimated $25,799
- XTX TOPCO LTD added 57,119 shares (+119.8%) to their portfolio in Q2 2026, for an estimated $19,991
- JANE STREET GROUP, LLC added 48,093 shares (+174.0%) to their portfolio in Q2 2026, for an estimated $16,832
- COMMONWEALTH EQUITY SERVICES, LLC removed 44,798 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $15,679
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
